Skip to main content
. 2017 Jan 18;2017(1):CD011285. doi: 10.1002/14651858.CD011285.pub2

Comparison 1. Exercise vs control.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Exercise capacity: 6MWD 5 165 Mean Difference (IV, Random, 95% CI) 60.12 [30.17, 90.07]
2 Exercise capacity: VO2peak 4 145 Mean Difference (IV, Random, 95% CI) 2.41 [1.38, 3.44]
3 Exercise capacity: Peak power 4 145 Mean Difference (IV, Random, 95% CI) 16.44 [10.90, 21.99]
4 Exercisecapacity: Anaerobic threshold 3 66 Std. Mean Difference (IV, Random, 95% CI) 1.05 [0.53, 1.58]
5 HRQoL SF36: Physical component score 2 33 Mean Difference (IV, Random, 95% CI) 4.63 [0.80, 8.47]
6 HRQoL SF36: Mental component score 2 33 Mean Difference (IV, Random, 95% CI) 4.17 [0.01, 8.34]
7 Adverse events 5 165 Risk Difference (M‐H, Random, 95% CI) 0.00 [‐0.04, 0.04]
8 HRQoL SF36: Physical function 4 118 Mean Difference (IV, Random, 95% CI) 6.13 [‐3.73, 16.00]
9 HRQoL SF36: Role physical 4 116 Mean Difference (IV, Random, 95% CI) 21.81 [14.40, 29.23]
10 HRQoL SF36: Bodily pain 3 88 Mean Difference (IV, Random, 95% CI) 5.64 [‐3.09, 14.36]
11 HRQoL SF36: General health 3 84 Mean Difference (IV, Random, 95% CI) 5.76 [‐0.80, 12.32]
12 HRQoL SF36: Mental health 3 87 Mean Difference (IV, Random, 95% CI) 6.21 [‐1.85, 14.27]
13 HRQoL SF36: Role emotional 3 87 Mean Difference (IV, Random, 95% CI) 2.79 [‐7.43, 13.01]
14 HRQol SF36: Vitality 4 115 Mean Difference (IV, Random, 95% CI) 13.47 [7.55, 19.40]
15 HRQoL SF36: Social function 4 118 Mean Difference (IV, Random, 95% CI) 14.01 [9.82, 18.21]
16 HRQoL: CAMPHOR activities 2 33 Mean Difference (IV, Random, 95% CI) ‐1.33 [‐3.56, 0.90]
17 HRQoL: CAMPHOR symptoms 2 36 Mean Difference (IV, Random, 95% CI) ‐3.08 [‐7.78, 1.62]
18 HRQoL: CAMPHOR QoL 2 36 Mean Difference (IV, Random, 95% CI) ‐5.42 [‐8.03, ‐2.81]
19 Cardiopulmonary haemodynamics 1   Mean Difference (IV, Random, 95% CI) Subtotals only
20 Functional class 2 40 Mean Difference (IV, Random, 95% CI) ‐0.60 [‐0.85, ‐0.35]
21 B‐type natriuretic peptide 1   Mean Difference (IV, Random, 95% CI) Subtotals only
22 Exercise capacity: 6MWD, sensitivity analysis 4 86 Mean Difference (IV, Random, 95% CI) 67.91 [27.12, 108.69]
23 Exercise capacity: VO2peak, sensitivity analysis 3 66 Mean Difference (IV, Random, 95% CI) 1.94 [0.86, 3.01]
24 Exercise capacity: Peak power, sensitivity analysis 3 66 Mean Difference (IV, Random, 95% CI) 15.27 [8.57, 21.97]
25 Exercise capacity 6MWD, PAH subgroup only 2 36 Mean Difference (IV, Random, 95% CI) 33.84 [0.95, 66.73]
26 Exercise capacity: VO2peak, PAH subgroup only 2 36 Mean Difference (IV, Random, 95% CI) 1.28 [‐0.19, 2.75]
27 Exercise capacity: Peak power, PAH subgroup only 2 36 Mean Difference (IV, Random, 95% CI) 14.24 [5.78, 22.70]
28 Exercise capacity: Anaerobic threshold, PAH subgroup only 2 36 Mean Difference (IV, Random, 95% CI) 41.31 [‐52.05, 134.67]
29 Exercise capacity: 6MWD, subgroup analysis for setting of rehabilitation 5   Mean Difference (IV, Random, 95% CI) Subtotals only
29.1 Inpatient exercise training 3 129 Mean Difference (IV, Random, 95% CI) 72.79 [28.09, 117.49]
29.2 Outpatient exercise training 2 36 Mean Difference (IV, Random, 95% CI) 33.84 [0.95, 66.73]